rTMS theray in CFS/ME

JRCT ID: jRCT1042240065

Registered date:01/08/2024

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Myalgic encephalomyelitus
• Date of first enrollment: 03/04/2018
• Target sample size: 100
• Study type: Interventional
• Intervention(s): Noninvasive repetitive transcranial magnetic stimulation is delivered to the left dorsolateral prefrontal cortex and primary motor area in the brain of participants.

Outcome(s)

• Primary Outcome: Amelioration of fatigue, general malaise, post-exertional malaise, brain fog, and unrefreshing sleep
• Secondary Outcome: Amelioration of pain, muscle weakness, and orthostatic intolerance

Key inclusion & exclusion criteria

• Age minimum: >= 15age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Patients with myalgic encephalomyelitus daignosed with ICC2011

Exclude criteria

Patients with serious complications
Pregnant or lactating women

Related Information

• Primary Sponsor: Miwa Kunihisa